REILLY FINANCIAL ADVISORS, LLC - SYNDAX PHARMACEUTICALS INC ownership

SYNDAX PHARMACEUTICALS INC's ticker is SNDX and the CUSIP is 87164F105. A total of 85 filers reported holding SYNDAX PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 0.03 and the average weighting 0.3%.

Quarter-by-quarter ownership
REILLY FINANCIAL ADVISORS, LLC ownership history of SYNDAX PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2021$45,000
+2.3%
2,0000.0%0.00%0.0%
Q4 2020$44,000
+46.7%
2,0000.0%0.00%
+33.3%
Q3 2020$30,0000.0%2,0000.0%0.00%
-25.0%
Q2 2020$30,000
+36.4%
2,0000.0%0.00%
+33.3%
Q1 2020$22,000
+22.2%
2,0000.0%0.00%
+50.0%
Q4 2019$18,000
+20.0%
2,0000.0%0.00%0.0%
Q3 2019$15,000
-21.1%
2,0000.0%0.00%0.0%
Q2 2019$19,000
+72.7%
2,0000.0%0.00%
+100.0%
Q1 2019$11,000
+22.2%
2,0000.0%0.00%0.0%
Q4 2018$9,0002,0000.00%
Other shareholders
SYNDAX PHARMACEUTICALS INC shareholders Q1 2020
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 2,168,691$30,297,00013.16%
Boxer Capital, LLC 234,220$3,272,0000.78%
SPHERA FUNDS MANAGEMENT LTD. 296,310$4,139,0000.70%
Ghost Tree Capital, LLC 200,000$2,794,0000.58%
Eventide Asset Management 225,000$3,143,0000.20%
Vident Investment Advisory, LLC 103,558$1,447,0000.12%
J. Goldman & Co LP 147,181$2,056,0000.11%
TIVERTON ASSET MANAGEMENT LLC 137,732$1,924,0000.10%
Crestline Management, LP 55,368$773,0000.10%
Tekla Capital Management LLC 200,000$2,794,0000.10%
View complete list of SYNDAX PHARMACEUTICALS INC shareholders